Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexeo Therapeutics (LXEO) EBIT Margin (2022 - 2023)

Historic EBIT Margin for Lexeo Therapeutics (LXEO) over the last 2 years, with Q4 2023 value amounting to 29948.0%.

  • Lexeo Therapeutics' EBIT Margin changed N/A to 29948.0% in Q4 2023 from the same period last year, while for Dec 2023 it was 33420.49%, marking a year-over-year change of. This contributed to the annual value of 77201.46% for FY2024, which is 437804800.0% up from last year.
  • Per Lexeo Therapeutics' latest filing, its EBIT Margin stood at 29948.0% for Q4 2023.
  • Over the past 5 years, Lexeo Therapeutics' EBIT Margin peaked at 38986.54% during Q3 2023, and registered a low of 3292.28% during Q3 2022.